Boston Scientific Statistics
Total Valuation
BVMF:B1SX34 has a market cap or net worth of BRL 590.38 billion. The enterprise value is 647.82 billion.
| Market Cap | 590.38B |
| Enterprise Value | 647.82B |
Important Dates
The last earnings date was Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.58% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 93.76% |
| Float | 1.48B |
Valuation Ratios
The trailing PE ratio is 36.99 and the forward PE ratio is 21.83.
| PE Ratio | 36.99 |
| Forward PE | 21.83 |
| PS Ratio | 5.34 |
| PB Ratio | 4.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 40.58 |
| EV / Sales | 6.18 |
| EV / EBITDA | 22.16 |
| EV / EBIT | 29.11 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 2.15 |
| Debt / FCF | n/a |
| Interest Coverage | 12.21 |
Financial Efficiency
Return on equity (ROE) is 12.68% and return on invested capital (ROIC) is 10.59%.
| Return on Equity (ROE) | 12.68% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.59% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 7.32% |
| Revenue Per Employee | 2.09M |
| Profits Per Employee | 301,173 |
| Employee Count | 53,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BVMF:B1SX34 has paid 2.72 billion in taxes.
| Income Tax | 2.72B |
| Effective Tax Rate | 14.56% |
Stock Price Statistics
The stock price has decreased by -34.98% in the last 52 weeks. The beta is 0.66, so BVMF:B1SX34's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -34.98% |
| 50-Day Moving Average | 509.68 |
| 200-Day Moving Average | 550.22 |
| Relative Strength Index (RSI) | 22.64 |
| Average Volume (20 Days) | 69 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.86 |
Income Statement
In the last 12 months, BVMF:B1SX34 had revenue of BRL 110.57 billion and earned 15.96 billion in profits. Earnings per share was 10.69.
| Revenue | 110.57B |
| Gross Profit | 77.66B |
| Operating Income | 23.48B |
| Pretax Income | 18.64B |
| Net Income | 15.96B |
| EBITDA | 30.85B |
| EBIT | 23.48B |
| Earnings Per Share (EPS) | 10.69 |
Balance Sheet
The company has 7.02 billion in cash and 66.34 billion in debt, with a net cash position of -59.32 billion.
| Cash & Cash Equivalents | 7.02B |
| Total Debt | 66.34B |
| Net Cash | -59.32B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 130.15B |
| Book Value Per Share | 86.93 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.24%, with operating and profit margins of 21.24% and 14.44%.
| Gross Margin | 70.24% |
| Operating Margin | 21.24% |
| Pretax Margin | 16.86% |
| Profit Margin | 14.44% |
| EBITDA Margin | 27.90% |
| EBIT Margin | 21.24% |
| FCF Margin | n/a |
Dividends & Yields
BVMF:B1SX34 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.58% |
| Shareholder Yield | -0.58% |
| Earnings Yield | 2.70% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |